Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2015 Oct 22;4(10):e002314.
doi: 10.1161/JAHA.115.002314.

Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis

Suresh Basnet  1 , Andrzej Kozikowski  2 , Amgad N Makaryus  3 , Renee Pekmezaris  2 , Roman Zeltser  3 , Meredith Akerman  4 , Martin Lesser  4 , Gisele Wolf-Klein  5
Affiliations
Multicenter Study

Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis

Suresh Basnet et al. J Am Heart Assoc. .

Abstract

Background: Although animal studies have documented metformin's cardioprotective effects, the impact in humans remains elusive. The study objective was to explore the association between metformin and myocardial infarct size in patients with diabetes presenting with ST-segment elevation myocardial infarction.

Methods and results: Data extraction used the National Cardiovascular Data CathPCI Registry in all patients with diabetes aged >18 years presenting with ST-segment elevation myocardial infarction at 2 academic medical centers from January 2010 to December 2013. The exposure of interest was ongoing metformin use before the event. Propensity score matching was used for the metformin and nonmetformin groups on key prognostic variables. All matched pairs had acceptable D scores of <10%, confirming an efficient matching procedure. The primary outcome was myocardial infarct size, reflected by peak serum creatine kinase-myocardial band, troponin T, and hospital discharge left ventricular ejection fraction. Of all 1726 ST-segment elevation myocardial infarction cases reviewed, 493 patients had diabetes (28.5%), with 208 metformin users (42.1%) and 285 nonusers. Matched pairs analysis yielded 137 cases per group. The difference between metformin and nonmetformin groups was -18.1 ng/mL (95% CI -55.0 to 18.8; P=0.56) for total peak serum creatine kinase-myocardial band and -1.1 ng/mL (95% CI -2.8 to 0.5; P=0.41) for troponin T. Median discharge left ventricular ejection fraction in both groups was 45, and the difference between metformin and nonmetformin users was 0.7% (95% CI -2.2 to 3.6; P=0.99).

Conclusions: No statistically significant association of cardioprotection was found between metformin and myocardial infarct size in patients with diabetes and acute ST-segment elevation myocardial infarction.

Keywords: ST‐segment elevation myocardial infarction; metformin; myocardial injury.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Propensity score matching flow diagram. NCDR indicates National Cardiovascular Data Registry; STEMI, ST‐segment elevation myocardial infarction.
See this image and copyright information in PMC

References

    1. American Heart Association . Cardiovascular disease and diabetes. Available at: http://www.heart.org/HEARTORG/Conditions/Diabetes/WhyDiabetesMatters/%20.... Accessed August 31, 2014.
    1. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta‐analysis of randomized trials. J Am Med Assoc. 2007;298:1180–1188. - PubMed
    1. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356:2457–2471. - PubMed
    1. Nissen SE, Wolski K. Rosiglitazone revisited: an updated meta‐analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med. 2010;170:1191–1201. - PubMed
    1. Ghotbi AA, Køber L, Finer N, James WPT, Sharma AM, Caterson I, Coutinho W, Van Gaal LF, Torp‐Pedersen C, Andersson C. Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes a substudy of the SCOUT trial. Diabetes Care. 2013;36:3746–3753. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources